COMMISSION OF THE EUROPEAN COMMUNITIES 
Brussels, 08.01.1998 
COM(97) 670 final 
COMMUNICATION FROM THE COMMISSION 
TO THE COUNCIL AND THE EUROPEAN PARLIAMENT 
WITH A VIEW TO ESTABLISHING A COMMON EUROPEAN UNION 
PLATFORM FOR THE SPECIAL SESSION OF THE UN GENERAL 
ASSEMBLY ON INTERNATIONAL COOPERATION 
IN THE FIGHT AGAINST DRUGS 
The aim of this Communication is to help prepare the EU position for the 
Special Session of the UN General Assembly on international action to combat 
drug abuse and illicit drug production and trafficking (UNGASS). 
The decision to convene this Special Session for 8-10 June 1998 was taken in 
Resolution 51/64 of the General Assembly at its Plenary meeting of 12 
December 1996. This resolution also established that the UN Commission on 
Narcotic Drugs (CND) would act as the preparatory body for the Special 
Session. 
In March 1997, the CND established the agenda for UNGASS, namely an 
assessment of the situation, and the establishment of principles for action on 
chemical precursors, synthetic drugs, money laundering, demand reduction, 
judicial cooperation, alternative development ,and strengthening of the UN drug 
control mechanisms. It also decided on the nature of, and calendar for, the 
preparatory meetings to take place. 
Of the four preparatory meetings proposed, two have already taken place (in 
July 1997 on chemical precursors and synthetic drugs; and in October 1997 on 
money laundering, judicial cooperation and demand reduction). A third meeting 
will take place in December 1997 on alternative development and to prepare 
elements for a political declaration. The last preparatory meeting is planned for 
March 1998 to finalise all the documents to be presented at UNGASS. 
In line with past Commission practice, the objective of this Communication is to 
launch discussions with and among Member States of the European Union, with 
a view to establishing a common European platform for the Special Session of 
the General Assembly. 
COMMUNICATION FROM THE COMMISSION 
TO THE COUNCIL AND THE EUROPEAN PARLIAMENT 
WITH A VIEW TO ESTABLISHING A COMMON EUROPEAN UNION 
PLATFORM FOR THE SPECIAL SESSION OF THE UN GENERAL 
ASSEMBLY ON INTERNATIONAL COOPERATION 
IN THE FIGHT AGAINST DRUGS 
I- THE INTERNATIONAL SITUATION: DRUGS AS A GROWING AND COSTLY 
INTERNATIONAL THREAT 
Drugs have become one of the major threats to humanity today. Individual and public health, 
social harmony, public safety, political stability and overall security are frequently threatened 
by the production, trafficking and consumption of illicit drugs. The huge size of illicit drug 
profits dwarfs the nonetheless large amounts of national and international resources devoted to 
preventing these illegal activities. 
The economic costs of drug abuse in OECD countries, including expenditure on law 
enforcement, prevention programmes and health care for drug-related diseases, currently 
amount to about $120 billion per year.1 The contrast with the regularly quoted estimates of 
drug profits of between $300 and $500 billion2, shows the dimensions of the problem, 
particularly when it is considered that Africa's total GNP is barely above $300 billion and that 
Foreign Direct Investment outflows throughout the world averaged $245 billion per year over 
the period 1990-953. 
The fact that the situation has not become any better since the international community 
formally addressed the issue in an earlier Special Session of the UN General Assembly 
(UNGASS) in 1990 shows the need to adapt to a changing international environment, to assess 
the impact of current efforts and to draw lessons from the policy experience to date. 
A number of indicators show that in spite of encouraging signs, and notwithstanding evident 
disparities among countries, global trends have hardly improved in recent years. Driven by 
steady demand, production of the major so-called natural drugs has continued to increase: 
opium production increased by 20% from 1990 to 1994, while coca leaf production tripled 
1 UNDCP, Report on the Economic and Social consequences of drug abuse and illicit trafficking, 1997 
2 UNDCP, World Drug Report, Oxford University Press, 1997, p. 124 
3 United Nations, Handbook of Trade and Development Statistics, Tables 6.1 and 5.3 respectively, New York and 
Geneva 1997 
from 1987 to 19944. At the same time, the production of synthetic drugs, mostly in advanced 
economies, has exploded in the last decade. 
As regards consumption of illicit drugs, two main changes are particularly disturbing. Drug 
consumption is no longer a nearly-exclusively industrialised countries' problem, but is 
becoming a serious problem in a number of developing countries. At the same time, the marked 
increase in synthetic drug consumption is also becoming a major source of concern5. 
The world of drugs has thus become highly globalized and the old distinction between 
producing /trafficking and consuming countries is increasingly irrelevant. While debating the 
reasons for the widespread character and intensity of these phenomena is beyond the scope of 
this Communication, no serious effort at fighting drugs can take place without an analysis of 
some of the main forces at work. After all, while drugs have always existed and their abuse has 
often been a source of individual and family distress, it is only in recent years that they have 
become a major health and social problem. Three main factors, all significant for the 
understanding of the problem and the search for effective solutions, seem to account for this 
development. 
Firstly, the huge profits associated with drug production and trafficking allows the suppliers to 
take great risks in their efforts to make drugs available and thus make it worthwhile to supply 
them. Indeed, the legal prohibition of illicit drugs raises their black market price, thus making 
such drugs harder to obtain, and therefore reducing their consumption. Yet, perversely enough, 
it not only encourages the use of more dangerous substitutes, but also contributes to the 
accumulation of large profits by organised crime. 
Secondly, two seemingly opposite factors paradoxically fuel a seemingly insatiable market for 
illicit drugs. One is increasing purchasing power resulting from rising incomes. The other is 
increasing social and cultural marginalization, in both industrialised and developing societies. 
In this way, while the poorer groups are more likely to fall into the drugs trap, the drugs 
spectrum ends up covering all social classes. 
4 UN Secretariat, "Crops from which drugs are extracted and appropriate strategies for their reduction", 
E/CN.7/1996/11, 1 March 1996 
5 As regards illicit consumption in Europe, the 1997 report from the European Monitoring Centre on Drugs and 
Drug Addiction (EMCDDA) gives an enlightening picture of the present trends. This is'notwithstanding the 
difficulty of such an analysis which results from both the illegal character of drug abuse and the lack of 
harmonisation of practices in data collection in the EU. The main findings are that, throughout the EU, 
cannabis is the most commonly-used illegal drug yet this use is commonly occasional or intermittent rather than 
frequent; that in most countries amphetamines are the second most-frequently used illegal drug and that since 
the late 1980s many countries are reporting that amphetamines, ecstasy, and in some cases LSD, have become 
more popular among young people, linked to a youth culture based around discotheques and large "house" 
parties; that EU populations have less experience of heroin (1%) than of almost any other drugs though heroin 
continues to dominate among populations identified as having problems related to drug use and remains a major 
threat to public health and public safety; that more people have tried cocaine than heroine (4%); that 
combinations of drugs, including medicines and alcohol, play a continuing and increasingly important part in 
drugs problems; that capital cities tend to have problem use rates higher than provincial cities and higher than 
national rates; that related health risks like AIDS and Hepatitis C are serious public health risks (there may be 
half a million drug users infected with hepatitis C in the European Union and that this disease is 50 to 100 times 
more infectious than AIDS). 
Thirdly, the continued improvements in means of transportation and communication make 
deliveries, financial transactions and money laundering easier and cheaper than ever. The 
globalization of economic activities and the Internet revolution with its drug-manufacturing 
and -using information availability are just the most recent steps on this ladder. 
II. FACING THE INTERNATIONAL THREAT 
Both the magnitude of the problems and the interdependencies associated with it require that 
national efforts be supported by international cooperation. Furthermore, as supply and demand 
reduction mutually reinforce each other, societies must act simultaneously on the demand and 
on the supply sides, the latter including production and trafficking of illicit drugs and money 
laundering. On both grounds, the principle of shared international responsibility must preside 
over all efforts to address the issue of drug control if there is to be any serious hope of success. 
In this regard, higher priority must be attached to five lines of approach: 
• integration of drug control components into mainstream policies such as health, 
education and research; 
• promotion of sustainable development in the broadest sense, as drug production and 
trafficking is a consequence of differences in relative profitability of economic 
activities and often results from the absence of opportunities for lawful sources of 
employment and income; 
• focusing drug control based on the strategic viewpoint that consumption of the most 
dangerous drugs results not only from individuals' choices but also from social 
conditions that marginalise certain groups in society; 
• encouragement of primary prevention, treatment and rehabilitation through, among 
other things, preventive education, research on the immediate and long-term effects on 
human health, and information on drugs as a source of psychiatric disorders; 
• strengthening of law enforcement through judicial/police/customs action on producers 
and traffickers and on money laundering, so as to narrow expected profit margins of 
drug suppliers and thus reduce the opportunities for their enrichment. 
To ensure the impact on the world-wide drug situation of these lines of approach, coordination 
at the international level as well as a common understanding of the issues at stake and the 
measures to be taken is needed. This is where the UN system can be at its most effective since 
its global membership and Convention-making capacities mean that it is particularly well-
placed for the task of addressing cross-frontier problems. 
Indeed, it is within the framework of the UN institutions that a body of legally-binding 
instruments has been developed. It is also in this framework that an international convergence 
has taken place as regards both the importance of the problem and the broad strategy to follow 
for drug-fighting. This is notwithstanding the fact that there are significant disagreements 
among countries on the relative weight to be given to the various facets of the problem and thus 
on the priorities and methods for implementing specific policies. 
III. THE UNION'S BROAD OBJECTIVES FOR UNGASS 
Illicit drugs have important implications for the stability, security and well-being of the 
countries and citizens of the Union and of the world. To the extent that the preservation of 
these is an objective in the UN Charter, as well as in the Treaty on European Union, the 
Community and its Member States have a major responsibility in ensuring the success of 
UNGASS. Both our citizens and our international partners expect us to exercise this 
responsibility. The endorsement by the 1995 Cannes and Madrid, and 1996 Dublin European 
Councils of the 1990-1995 EU Action Plan to fight drugs provides political legitimacy to those 
expectations. 
However, as in any other major international conference, a balance must be struck between 
forward-looking wishes and pragmatic expectations. Indeed, the European Union has to be 
realistic about what can be achieved in this session, as it cannot expect (even though it might 
wish) that, in the immediate future, all countries will adopt and implement the far-reaching 
legislation and measures its Members apply. Yet, at the same time, the Union must be forceful 
in encouraging the international community to examine current efforts, to address new threats 
and to put shared responsibility at the centre of the international fight against drugs. 
Three major objectives must determine the Union's efforts towards a successful conclusion of 
UNGASS: 
• the consolidation and the practical implementation of the principle of co-
responsibility, in accordance with the UN Resolution which launched UNGASS6 and 
with the 1995 EU-Rio Group Declaration of Cochabamba which, for the first time, 
made this principle explicit in EU external relations; 
• the provision of political impetus throughout the UN Member States, so that drug-
fighting is at the top of the international agenda and an integral part of mainstream 
policies; 
• the achievement of policy advances in areas on which the Union has already defined 
its interest and has exhibited a degree of consensus. 
The latter applies in particular to reaching agreement on a Declaration on the prevention of the 
abuse of illicit drugs ("Guiding principles of drug demand reduction"), which will be a major 
innovation as compared with the UN conventions, which address this question only marginally. 
It is also the case as regards the new threats posed by synthetic drugs. There is a need to spell 
out the implications of international co-responsibility. Likewise, it is in the Union's interest to 
encourage advances in areas of Community competence, particularly as regards money 
laundering and chemical precursor control. As regards the former, it is important to push for a 
general acceptance of the FATF forty recommendations and for stronger action on financial 
safe-havens. Precursor control, on the other hand, has important implications for trade policy. 
Finally, there is a need to foster the role of the UN institutions in the fight against drugs and 
encourage the universal ratification of UN instruments. 
6 International action to combat drug abuse and illicit production and trafficking. Resolution 55/64 of December 
1996. 
This Special Session of the UN takes place as part of a series of UN Conferences and Summits 
(Rio, Vienna, Cairo, Beijing, Copenhagen) the aim of which is the promotion of people-
centred sustainable development. The way the drug issue is tackled must be in conformity with 
the commitments entered into by the international community in this framework, especially as 
regards the full respect for human rights and fundamental freedoms. 
IV. THE UNION'S SPECIFIC PRIORITIES FOR UNGASS 
In parallel with the preparatory process in UN bodies, the Union is both bound and eager to 
discuss UNGASS at bilateral and regional meetings (including the San Jose and EU-Rio Group 
ministerials, EU-ASEAN and EU-ACP dialogues, etc.) in the early part of 1998. It is, thus, 
particularly important that the Union establishes a common set of priorities on the main issues 
to be addressed at UNGASS. 
In March 1997, at the time the CND set up the agenda for the preparatory process for 
UNGASS, a number of topics were singled out for debate during this process. In chronological 
order these were: chemical precursors, synthetic drugs, judicial cooperation, money laundering, 
alternative development, demand reduction. 
The Union's contributions regarding these and other related topics should focus on: 
A. Demand reduction 
1. Emphasis on demand reduction as a critical instrument in any drug-fighting strategy. 
2. A strong accent on the relationship between demand reduction and social integration and 
cohesion. In particular, there is a the need to build on policies which allow all people to 
participate fully in society and which promote human values which include, for a great 
many, a spiritual aspiration. Fighting against drugs calls for an effective priority to be given 
to job creation, especially for young people, more inclusive social protection systems, 
supportive public services, and a social environment that strengthens family structures. 
3. Recognition that drug demand reduction covers all areas of prevention, from discouraging 
initial use to reducing the negative health and social consequences of drug abuse. Thus, it 
encompasses information, education, public awareness, early intervention, counselling, 
treatment, rehabilitation, relapse prevention, aftercare and social-réintégration. 
4. Support for research on the biological, medical and socio-economic aspects of drug 
addiction and on the impact of drug abuse on human health and life expectancy. 
5. Importance of fostering both the integration of drug concerns into mainstream policies and 
coordination among the different policies and programmes which have an impact on drug 
demand reduction (most notably research, education and training, health and legal 
measures), and of supporting demand reduction activities through adequate means of 
assessment and evaluation. 
6. Need to stimulate exchanges of experience and information - taking due account of cultural 
background and specificity - on the best health and social initiatives. Particularly important 
in this regard are those based on community partnership, society involvement and actions in 
respect of vulnerable groups such as young people, drug abusers and former drug abusers. 
7. Need to redefine national health policies, in developing countries in particular, so as to 
integrate demand reduction aspects of drugs control into existing health programmes. 
B. Synthetic drugs 
1. Acknowledgement that, compared with other types of drugs and psychotropic substances, 
the emergence and development of new synthetic drugs has become an acute problem in the 
world and poses special challenges: they are easy to produce, their chemical structures 
change frequently and many types of precursors can be used for making them. 
2. Recognition that the social perception of the so-called "designer drugs" has been very 'soft', 
and thus not commensurate with their risks and the ease with which these drugs can be 
manufactured. 
3. Emphasis on the need to obtain accurate information regarding the issue of synthetic drugs 
and thus to initiate research, increase knowledge and collect relevant data on the health 
effects of, as well as on the social, economic and cultural factors behind, the consumption of 
amphetamine-type stimulants (ATS) and to exchange and disseminate this information. The 
example of the European Union work in this regard7 can be used in support of this proposal. 
4. Recognition of the need to strengthen the control system for new synthetic drugs and their 
precursors. The joint action adopted by the Council on 16 June 1997 concerning information 
exchange, risk assessment and the control of new synthetic drugs to provide the basis for 
bringing under control new synthetic drugs can be offered as an example for addressing this 
need. Likewise, the more flexible scheduling mechanisms for psychotropic substances 
(emergency list, analogues, generic approach) under examination in some EU Member 
States, can also be referred to. 
5. As regards prevention campaigns, emphasis on appropriate action targeted at young people, 
in line with efforts by the Community Action Programme on the Prevention of Drug 
Dependence. 
6. In the light of the above, endorsement of the draft Action Plan against the manufacture, 
trafficking and abuse of ATS, proposed at July's CND preparatory meeting for UNGASS. 
7 More particularly, the information provided by both the EMCDDA and the Europol Drugs Unit (EDU) on the 
levels of consumption of, and trafficking in, synthetic drugs. Equally significant are the transnational pilot 
projects supported by the European Community and aimed at building up a system to recognise trends in 
consumption among the young, to assess prevalence of drug use in particular settings such as techno-scenes 
and to develop transnational exchange of data. Finally, research priorities regarding the particular dangers 
posed by synthetic drugs have been identified by the Community in three areas: medical, pharmacological 
and toxicological; psychological and sociological; and epidemiological and monitoring. 
C. Alternative development 
1. Reaffirmation of alternative development as a move from a production system based on 
illicit cultivation towards a licit one, taking into account not only its economic dimension 
but, more broadly, the overall living conditions of the affected populations. 
2. Recognition that alternative development is primarily the responsibility of the countries 
where production of illicit drugs takes place. Alternative development should be supported 
by international cooperation, as long as there are guarantees that the programmes will ensure 
the definitive abandonment of illicit cultivation. 
3. Recognition that alternative development is not conceivable without a case-by-case dialogue 
among the potential populations affected, the public authorities and, possibly, international 
donors. This dialogue should be on choices regarding new alternative sources of income and 
employment, and on calendars for shifting economic activities from illicit to licit 
productions, all of which implies the recognition of de-ceQtralised structures and democratic 
participation. 
4. Need for an efficient and credible monitoring and verification mechanism, based on 
commonly agreed goals and objectives to guarantee the sustainability of eradication. This 
system needs not only the support of the country's administration, but also the involvement 
of affected populations through their representative institutions. 
D. Chemical precursors 
1. Recognition that a solely law-enforcement approach has its limits: precursor diversion is the 
exception to licit trade transactions; so efforts to counter diversion have to take into due 
consideration the legitimate needs of licit trade. Therefore, co-operation with industry is 
essential. 
2. Acceptance that the most effective way to tackle precursors diversion is by targeting the 
international precursors control mechanism towards a specific and limited number of 
chemicals under a system consistent with the nature and trade patterns of each product. 
3. Recognition that precursor diversion is a three-way problem, with a shared responsibility for 
importers, transit countries and exporters. Therefore, it is important to ensure that the 
appropriate means are put in place to curb diversion at a global level: countries, notably 
importing and transit States, should identify and provide regular up-dates to their partners on 
their focal points for sending and receiving of information on precursor consignments; 
importing countries should provide timely feed-back on pre-export notifications. Whenever 
a consignment is suspected of being diverted, timely information should be distributed to the 
relevant administrative bodies within the affected countries so that action is taken in good 
time. 
4. Bilateral agreements with third countries are to be encouraged as they contribute to a 
widespread information-sharing in the combat against precursors diversion and can be a 
useful tool for maintaining, enhancing and extending the precursors control system. These 
agreements, when they are part of a regional approach, can take account of the cross-
boundary nature of precursors'diversion. 
5. In the light of the above, support for the draft Plan of Action for Precursors presented at the 
CND preparatory meeting of July 1997, as long as it ensures that its envisaged control 
system is practicable and that data protection is ensured when sharing sensitive information. 
6. As to precursors for new synthetic drugs, inappropriateness of establishing a control 
mechanism similar to that imposed on the 22 scheduled substances in the 1988 Vienna 
Convention as these precursors have a rapidly evolving nature. Therefore, expanding the 
number of substances could only result in weakening the global efficiency of the precursor 
control system while hampering the co-operation between operators and the authorities. 
7. Reference to the establishment of "special surveillance lists" for non-scheduled precursors 
used in the manufacturing of synthetic drugs provided those lists reflect the contracting 
parties' national and regional needs, the evolving nature of any such surveillance list and the 
principle of co-operation with industry and trade. 
E. Money laundering 
1. Recognition that huge profits are the driving force of the international drugs trade. The vast 
sums generated are used to develop and facilitate the drugs trade, finance other criminal 
activities and, once laundered, they are also invested in physical and financial assets, in real 
estate and in other legitimate businesses. 
2. Acceptance that, contrary to the frequent perception that financial inflows into a country are 
always desirable and beneficial, dirty money ultimately undermines the social, judicial and 
political stability of vulnerable countries. It also has dangerous macro-economic effects and 
can undermine and destroy confidence in the legitimate financial sector. 
3. Recognition that the prevention of money laundering, the prosecution and conviction of 
money launderers, and the pursuit and confiscation of criminal money form an integral part 
of the effort to combat drugs. 
4. Wider acceptance that, as reflected at UN level in the link-up between UNDCP and the 
Division for Crime Prevention and Criminal Justice, it is no longer sufficient to target solely 
the laundering of drugs money. The criminalisation of money laundering pre-supposes an 
underlying criminal offence. The wider the range of sanctions, the easier it is to pursue 
criminal money and establish the necessary international cooperation. 
5. Call for determined action against all forms of financial or corporate safe-havens for illicit 
funds. 
6. Affirmation that the best vehicle for a comprehensive and effective international effort 
against money laundering remains the Financial Action Task Force (FATF), and that the 
international standard to be followed is the FATF's 40 Recommendations. 
F. Corruption 
1. Recognition that corruption is intrinsically linked with illicit drug trafficking and other 
forms of organized crime. To conduct their criminal trade, to escape punishment, to conceal 
' 10 
their activities, to exert influence and to launder illicit profits, traffickers have recourse to 
corruption. 
2. Completion of currently discussed international legal instruments dealing with criminal law, 
namely the OECD draft convention on combating bribery of foreign public officials in 
international business transactions, and the Council of Europe draft convention on 
corruption. 
3. Raising of public awareness and promotion of public ethics, as well as calling for the 
provision of appropriate working and living conditions which protect vulnerable professions 
and targeted positions. 
4. Maintenance of a regulatory environment which guarantees as much transparency as is 
consistent with the need to achieve effectiveness. 
G. Judicial cooperation 
1. Emphasis on the ratification, where appropriate, of multilateral conventions for extradition 
and mutual assistance. 
2. Encouragement of bilateral treaties on extradition and mutual assistance, taking into account 
the guidelines set up in UN model treaties. 
3. As regards the answer to international mutual assistance requests dealing with serious 
crimes, need to attach a priority to them equivalent to that granted to national proceedings. 
4. Setting up of suitable mechanisms for exchanging information and facilitating contacts 
among judicial authorities. 
5. Support of exchange and training programs for magistrates and officials associated with the 
justice system. 
H. Strengthening of UN bodies for drugs control. 
1. Ensuring that the issue of UN reform in the drugs field remains on UNGASS' final agenda. 
This follows not only from the EU's strong commitment to overall UN reform, but also 
from the need to provide credibility for the entire UNGASS exercise which would be put 
into question if UN Members decided on new actions without providing the structurés and 
means to implement them effectively. 
2. Recognition of the need to improve the current structure and functioning of the UN bodies 
involved in drugs control. Acknowledgement that the Secretary General's UN reform 
proposals regarding the drugs field, even if implemented,8 do not address three current main 
8 Only two proposals of the UN Secretary General's comprehensive UN reform package concern directly the UN 
institutions dealing with drugs. One is the creation of a common managerial structure for the UNDCP and the 
Division for Crime Prevention and Criminal Justice. The other foresees the merger of the CND with the 
Commission on Crime Prevention and Criminal Justice. The first proposal has been dealt with in General 
11 
shortcomings: these are the functioning of the CND and the governance and financing of 
UNDCP.9 
3. Call for improvement in the agenda-setting process for CND and in the Secretariat's 
preparatory work for CND's meetings. The Secretariat's preparation should involve all the 
relevant UN bodies, including specialised agencies, Bretton Woods institutions and, where 
appropriate, civil society. It should also aim at facilitating the adoption of action-oriented 
recommendations to the UN bodies and to the Members of the UN. Call for improvement of 
the substance of the debates in CND and for systematic follow up to CND resolutions. 
4. Need to support the International Narcotics Control Board (INCB) in its capacity as an 
expert body for the practical implementation of the UN drug conventions, for analysing 
trafficking trends and for drawing up recommendations for the consideration of Member 
States in CND. 
5. Recognition that CND's strength lies in its normative role rather than in its present function 
as the governing body of UNDCP. Call for a more efficient governing structure that would 
promote dialogue between developing and developed countries and which would be in line 
with the existing governance structures of other UN funds and programmes. The new 
governing structure should consist of the present Major Donors and representatives from 
developing countries/regions. 
6. Call for improvement in the financing of UNDCP activities so that more funds are made 
available for core tasks, thus reducing the current concentration on voluntary contributions 
for UNDCP's operational activities. One of UNGASS' objectives should be to devise new 
funding approaches reflecting the principle of partnership, shared responsibility and capacity 
to pay, which would guarantee sufficient and predictable resources to finance the activities 
that UNDCP is expected to carry out. 
V. CONCLUSIONS 
Considerable efforts have been undertaken in the last two decades to address the drugs problem 
at the international level. The recognition of the importance of both demand reduction and of 
the threats posed by the new synthetic drugs are two cases in point. Yet, much remains to be 
done. 
What is most needed is to ensure the recognition of drugs as a global concern, the fight on 
which must be based on the principle of shared responsibility among producing, consuming 
and trafficking countries. 
Assembly Resolution A/RES/52/11 and has already been implemented. Whether the second proposal will be 
eventually approved by Member States is not certain. 
9 The problem of the functioning of the CND (or the new Commission still to be created ) is not addressed in the 
Secretary General's reform package. Likewise, the problem of UNDCP governance is not tackled at all. Finally, 
UNDCP financing is not addressed as such but some recommendations in the package, particularly as regards 
financing of development assistance could be of interest for the UNDCP. 
12 
Further, the drugs issue must be accepted as a cross-cutting issue in all international debates, 
whether the focus is on sustainable development or on security issues. In this context, priority 
should be given to schemes designed to foster cooperation and encourage response from host 
countries, rather than those which imply unilateral actions. 
The reduction in both demand for, and supply of, illicit drugs requires societal and policy 
changes to ensure income and employment growth and, frequently, a more equitable sharing in 
the fruits of development. The lack of sufficient progress in the fight against poverty, and 
towards more job opportunities and fairer social conditions, which was urged by the Social 
Development Summit, help create environments which are conducive to drug abuse as well as 
to the cultivation of, and trafficking in, illicit drugs. As, in spite of the efficiency gains brought 
about by globalization and by economic growth, social conditions seem to worsen in a number 
of countries and social groups, governments must ensure that options and choices remain open 
to disadvantaged groups. UNGASS provides a unique opportunity for raising the stakes and 
bringing producing, consuming and trafficking countries to face these complex common 
challenges. 
As a conclusion to the present Communication, the Commission therefore requests the 
Council: 
a) to take note of the present Communication and use it as its common platform for statements 
by the Community and its Member States during the Special Session; 
b) to take note that the Commission will present at UNGASS, on behalf of the Community, its 
agreed positions on chemical precursors; 
c) to authorise the Commission to endorse, on behalf of the Community, in the framework of 
its competences and after coordination with Member States, any political declaration or 
commitments which would be adopted at the Special Session and which are in c onformity 
with the principles, objectives and priorities laid out in this Communication; 
d) to note that the Commission will to this end closely consult with the Member States. 
13 
ISSN 0254-1475 
COM(97) 670 final 
DOCUMENTS 
EN 05 11 10 
Catalogue number : CB-CO-97-688-EN-C 
ISBN 92-78-28731-8 
Office for Official Publications of the European Communities 
L-2985 Luxembourg